XML 47 R35.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

12 Months Ended

Dec. 31, 2024

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]

Schedule of Assets Measured at Fair Value on Recurring Basis

The following represents assets measured at fair value on a recurring basis by the Company (in thousands):


December 31, 2024		Fair Value				Level 1				Level 2				Level 3
Assets:
Money market funds		$	14,687			$	14,687			$	—			$	—
Investment in iECURE			3,206				—				—				3,206
Imugene Marketable Securities			413				413				—				—
Assets held for sale			169				—				—				169
		$	18,475			$	15,100			$	—			$	3,375

Liabilities:
Final payment fee		$	194			$	—			$	194			$	—
Warrant liability			2,796				—				—				2,796
		$	2,990			$	—			$	194			$	2,796


December 31, 2023		Fair Value				Level 1				Level 2				Level 3
Assets:
Money market funds		$	13,960			$	13,960			$	—			$	—
Investment in iECURE			3,206				—				—				3,206
Imugene convertible note			11,897				—				11,897				—
Assets held for sale			487				—				—				487
		$	29,550			$	13,960			$	11,897			$	3,693

Liabilities:
Final payment fee		$	215			$	—			$	215			$	—
		$	215			$	—			$	215			$	—

Summary of Financial Assets Measured at Fair Value on Recurring Basis Using Significant Unobservable Inputs

The following represents a reconciliation of assets measured and carried at fair value on a recurring basis with the use of significant unobservable inputs (Level 3) for the year ended December 31, 2024 (in thousands). The warrant reconciliation is disclosed in Note 13, Warrants:


	Investment in iECURE				Assets held for sale
Balance December 31, 2023		$	3,206		$	487
Gains from changes in fair value included in earnings		—			—
Additions						16
Assets sold		—				(142	)
Write-offs		—				(192	)
Balance December 31, 2024		$	3,206		$	169

Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.

+ References + Details